US "actively engaged" in finding therapies for new Ebola strain, CDC says

The ​United States is "actively ​engaged" in ‌efforts to ​find therapies for the Bundibugyo strain of the Ebola ‌virus outbreak that has resulted in 160 suspected deaths out of 670 suspected cases in ‌the Democratic Republic of Congo, a U.S. CDC ‌official said on Friday.

"We are rapidly evaluating the landscape of products that are available, determining what products ⁠may ​be the ⁠most appropriate, and determining the best way that we ⁠can ensure the safe and effective delivery of ​therapeutics in the appropriate way to assess their ⁠efficacy," Dr. Satish Pillai, the incident manager for the ⁠CDC's ​Ebola response, said in a briefing.

The U.S. has the capacity to test ⁠for Ebola because of its integrated laboratory network, which ⁠is ⁠supported by the Centers for Disease Control and Prevention, Pillai said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)